Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 111 clinical trials
  • 0 views
  • 08 Apr, 2021
  • 1 location
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. (FIL_COLUMN)

This is a prospective, phase 2, multicenter, open-label, single-arm study. Primary objective is to assess the efficacy of loncastuximab tesirine given as consolidation therapy after salvage

  • 0 views
  • 15 May, 2022
  • 1 location
Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD

by comparison to historical controls based on the matched threshold crossing approach. During consolidation therapy (chemotherapy as well as allo-HCT) patients receive either prophylactic quizartinib

  • 0 views
  • 28 Jan, 2021
  • 1 location
Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML

patients entering a complete remission or a complete remission with incomplete blood count recovery will be allowed to proceed to consolidation therapy with vyxeos and gilteritinib. Those patients who do

  • 0 views
  • 04 Jul, 2022
  • 1 location
TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation (ATOMICC) (ATOMICC)

of TSR-042, checkpoint inhibitor, as consolidation therapy following concurrent chemo-radiation would increase PFS in these patients. The incorporation of immunotherapy after chemo-radiation is one

carcinoma
anticoagulants
liver metastasis
adenosquamous carcinoma
direct bilirubin
  • 34 views
  • 12 Feb, 2022
  • 25 locations
Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. (Lemon-C)

After standard treatment of primary central nervous system lymphoma (PCNSL), high-dose methotrexate induction therapy, and consolidation therapy, most patients reach complete remission

  • 0 views
  • 24 Mar, 2022
  • 1 location
PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

was obtained after salvage treatment, patients will receive GBM conditioning regimen followed by ASCT as consolidation therapy. High-risk R/R cHL patients will be treated with PD-1 inhibitor after

pd-1 inhibitor
lymphoma
platelet count
  • 0 views
  • 22 Dec, 2021
  • 1 location
Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma (PCNSL-LEM)

The study will include 28 patients with primary CNS DLBCL who are ineligible with autologous hematopoietic stem cell transplantation or whole brain radiation therapy as consolidation therapy

  • 0 views
  • 12 Mar, 2022
  • 1 location
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance

mutations. Because the relapse rate of patients with persistent mutations is expected to be high, treatment with either standard of care consolidation therapy alone or alloSCT will be permitted, at the

remission
consolidation chemotherapies
cell transplantation
hematologic disorder
cytarabine
  • 11 views
  • 24 May, 2022
  • 3 locations
Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML

leukemia, further clarify the efficacy of this regimen compared with traditional consolidation therapy, and initially confirm the effect of combined with unrelated cord blood transplantation in the

cytarabine
neoadjuvant therapy
remission
decitabine
consolidation therapy
  • 0 views
  • 03 Feb, 2022
  • 1 location